Altogether, these results indicate that Treg from T1D patients increased their expression of TNFRII during in vitro expansion, without changing the expression pattern of GARP on activated and expanded Treg, compared to those of healthy controls. This evidence concerns the gene TNFRSF1B and type 1 diabetes mellitus.